Plantar Temperature Response to Walking in Diabetes with and without Acute Charcot: The Charcot Activity Response Test

Objective. Asymmetric plantar temperature differences secondary to inflammation is a hallmark for the diagnosis and treatment response of Charcot foot syndrome. However, little attention has been given to temperature response to activity. We examined dynamic changes in plantar temperature (PT) as a function of graduated walking activity to quantify thermal responses during the first 200 steps. Methods. Fifteen individuals with Acute Charcot neuroarthropathy (CN) and 17 non-CN participants with type 2 diabetes and peripheral neuropathy were recruited. All participants walked for two predefined paths of 50 and 150 steps. A thermal image was acquired at baseline after acclimatization and immediately after each walking trial. The PT response as a function of number of steps was examined using a validated wearable sensor technology. The hot spot temperature was identified by the 95th percentile of measured temperature at each anatomical region (hind/mid/forefoot). Results. During initial activity, the PT was reduced in all participants, but the temperature drop for the nonaffected foot was 1.9 times greater than the affected side in CN group (P = 0.04). Interestingly, the PT in CN was sharply increased after 50 steps for both feet, while no difference was observed in non-CN between 50 and 200 steps. Conclusions. The variability in thermal response to the graduated walking activity between Charcot and non-Charcot feet warrants future investigation to provide further insight into the correlation between thermal response and ulcer/Charcot development. This stress test may be helpful to differentiate CN and its response to treatment earlier in its course.

[1]  J. T. Johnson Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. , 1967, The Journal of bone and joint surgery. American volume.

[2]  T. Saxby,et al.  Management of Midfoot Diabetic Neuroarthropathy * , 1994, Foot & ankle international.

[3]  S. Sinha,et al.  NEURO-ARTHROPATHY (CHARCOT JOINTS) IN DIABETES MELLITUS , 1972 .

[4]  D. Armstrong,et al.  Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. , 1997, Journal of rehabilitation research and development.

[5]  W. F. Todd,et al.  The Natural History of Acute Charcot’s Arthropathy in a Diabetic Foot Specialty Clinic , 1997, Journal of the American Podiatric Medical Association.

[6]  Leung Hb,et al.  Charcot foot in a Hong Kong Chinese diabetic population. , 2009 .

[7]  M B Silver-Thorn,et al.  Investigation of lower-limb tissue perfusion during loading. , 2002, Journal of rehabilitation research and development.

[8]  Bijan Najafi,et al.  Diabetic Foot Biomechanics and Gait Dysfunction , 2010, Journal of diabetes science and technology.

[9]  D. G. Armstrong,et al.  The consequences of complacency: managing the effects of unrecognized Charcot feet , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[10]  R. Frykberg,et al.  Epidemiology of the Charcot foot. , 2008, Clinics in podiatric medicine and surgery.

[11]  S. Sinha,et al.  Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). , 1972, Medicine.

[12]  D. Armstrong,et al.  Charcot's arthropathy of the foot. , 2002, Journal of the American Podiatric Medical Association.

[13]  Lee C. Rogers,et al.  The Charcot Foot in Diabetes , 2011, Diabetes Care.

[14]  Todd A. Lee,et al.  Lower-Extremity Amputation Risk After Charcot Arthropathy and Diabetic Foot Ulcer , 2009, Diabetes Care.

[15]  M. Dubský,et al.  Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients With Charcot Foot , 2009, Diabetes Care.

[16]  A. Vinik,et al.  Normal blood flow response and vasomotion in the diabetic Charcot foot. , 1998, Journal of diabetes and its complications.

[17]  W. F. Todd,et al.  Infrared dermal thermometry for the high-risk diabetic foot. , 1997, Physical therapy.

[18]  Wiebren Zijlstra,et al.  Does walking strategy in older people change as a function of walking distance? , 2009, Gait & posture.

[19]  P. Holstein,et al.  Long-term follow-up in diabetic Charcot feet with spontaneous onset. , 2000, Diabetes care.

[20]  A. Boulton,et al.  Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting? , 2004, Diabetologia.

[21]  W. Jeffcoate The causes of the Charcot syndrome. , 2008, Clinics in podiatric medicine and surgery.

[22]  K. Tada,et al.  The results of arthrodesis of the ankle for leprotic neuroarthropathy. , 1990, The Journal of bone and joint surgery. American volume.

[23]  W. Jeffcoate,et al.  Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot) , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[24]  Ryan T. Crews,et al.  Importance of Time Spent Standing for Those at Risk of Diabetic Foot Ulceration , 2010, Diabetes Care.

[25]  Bijan Najafi,et al.  Laboratory in a box: Wearable sensors and its advantages for gait analysis , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[26]  N. Petrova,et al.  Charcot neuro‐osteoarthropathy—current standards , 2008, Diabetes/metabolism research and reviews.

[27]  W. Jeffcoate,et al.  The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes , 2005, The Lancet.

[28]  C. Saltzman,et al.  Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. , 2004, The Journal of bone and joint surgery. British volume.

[29]  Kamiar Aminian,et al.  Spatio-temporal parameters of gait measured by an ambulatory system using miniature gyroscopes. , 2002, Journal of biomechanics.

[30]  D. Armstrong,et al.  Activity monitors: should we begin dosing activity as we dose a drug? , 2001, Journal of the American Podiatric Medical Association.

[31]  D. Clohisy,et al.  Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. , 1988, The Journal of bone and joint surgery. American volume.

[32]  Richard Hellman,et al.  Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. , 2008, Physical therapy.

[33]  D. Wukich,et al.  Charcot arthropathy of the foot and ankle: modern concepts and management review. , 2009, Journal of diabetes and its complications.

[34]  Joseph L. Mills,et al.  Comprehensive fool examination and risk assessment: A report of the task force of the foot care interest group of the American diabetes association, with endorsement by the American association of clinical endocrinologists , 2008 .

[35]  Gerard V. Yu,et al.  Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. , 2002, Journal of the American Podiatric Medical Association.

[36]  R. Frykberg,et al.  Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone , 2009, Diabetes Care.

[37]  J. Lahtela,et al.  Charcot Arthropathy of the Diabetic Foot. Current Concepts and Review of 36 Cases , 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.